newsfilter
← Latest News
Business Wire·

Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint

– Newly Completed Sensitivity Analyses Demonstrate Robustness of Previously Announced Survival Superiority Over External Control in Patients with TA-TMA – Sensitivity analyses support the results of the primary